Sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC): Updated phase I results from a phase I/II trial (NCI 6981) Meeting Abstract


Authors: Jeske, S.; Tagawa, S. T.; Milowsky, M. I.; Matulich, D.; Kung, S.; Sung, M. W.; Lehrer, D.; Kaplan, J.; Nanus, D. M.
Abstract Title: Sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC): Updated phase I results from a phase I/II trial (NCI 6981)
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 672s
Language: English
ACCESSION: WOS:000208457401833
DOI: 10.1200/jco.2008.26.15_suppl.16023
PROVIDER: wos
Notes: Meeting Abstract: 16023 -- Full text available online only -- Source: Wos
Altmetric Score
MSK Authors
  1. Janice E Kaplan
    3 Kaplan